EUVIMEDEUVIMED entdecken
Crossref

Statin use and longitudinal bone marrow lesion burden: analysis of knees without osteoarthritis from the Osteoarthritis Initiative study

Kamyar Moradi, Bahram Mohajer, Ali Guermazi, Roham Hadidchi, Soheil Mohammadi, Xu Cao, Mei Wan, Frank W Roemer, Shadpour Demehri

Skeletal Radiology · 2025-08 · 54 (8) · 1707-1714

DOI: 10.1007/s00256-025-04878-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skeletal Radiology, online erschienen am 31.01.2025. Verfasst von Kamyar Moradi und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, JHOC 3142, Ba…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Magnetic Resonance Imaging, Bone Marrow, Osteoarthritis, Knee. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NIA NIH HHS, NIAMS NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Knee subchondral bone marrow lesions (BMLs) are one of the hallmark features of structural osteoarthritis (OA) and are potential targets for statins' disease-modifying effect. We aimed to determine the association between statin use and longitudinal changes in magnetic resonance imaging (MRI)-based BML volume in participants without radiographic knee OA at baseline. METHODS: Using the Osteoarthritis Initiative (OAI) cohort, we classified participants' knees into two categories: statin users (those who consistently used statins from baseline to the fourth year of the cohort) and non-users. We employed a 1:1 ratio propensity score (PS) matching method, adjusting for factors including age, sex, race, BMI, smoking, alcohol use, physical activity, abdominal obesity, and diabetes mellitus. We measured quantitative BML volume using a validated deep learning (DL) algorithm, applied to baseline, year-2, and year-4 intermediate-weighted fat-saturated knee MRIs. The outcome was determined by the differences in the BML volume change between statin users and non-users over the 4-year period. RESULTS: After adjusting for potential confounders, 1502 knees were included (751 statin users and 751 non-users; mean age 63.5 ± 8.7 years, 44.5% female). A Multilevel linear mixed-effects regression model showed that statin use is associated with a smaller increase in BML volume over 4 years (time-treatment interaction effect estimates, 95% confidence interval (CI) - 14.88 mm3/year, - 23.04 to - 6.72, P < 0.001). CONCLUSION: In participants without baseline knee OA, continuous statin use is associated with a reduced longitudinal worsening of BML volume in the tibiofemoral joint, a known structural damage marker linked to downstream OA incidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsMagnetic Resonance ImagingBone MarrowOsteoarthritis, KneeKnee JointBone Marrow DiseasesHumansFemaleMaleMiddle AgedLongitudinal StudiesAged

Stichwörter der Autor:innen

Bone marrow lesionKnee osteoarthritisStatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, JHOC 3142, Baltimore, MD, 21287, USA. kamyarmoradi74@gmail.com.
  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, JHOC 3142, Baltimore, MD, 21287, USA.
  • Department of Radiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Radiology, Universitätsklinikum Erlangen & Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Förderung

  • NIA NIH HHS
  • NIAMS NIH HHS
  • National Institute on Aging
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Moradi, K., Mohajer, B., Guermazi, A., Hadidchi, R., Mohammadi, S., Cao, X., Wan, M., Roemer, F. W., & Demehri, S. (2025). Statin use and longitudinal bone marrow lesion burden: analysis of knees without osteoarthritis from the Osteoarthritis Initiative study. Skeletal Radiology, 54(8), 1707-1714. https://doi.org/10.1007/s00256-025-04878-6

Vancouver

Moradi K, Mohajer B, Guermazi A, Hadidchi R, Mohammadi S, Cao X, et al. Statin use and longitudinal bone marrow lesion burden: analysis of knees without osteoarthritis from the Osteoarthritis Initiative study. Skeletal Radiology. 2025;54(8):1707-1714. doi:10.1007/s00256-025-04878-6

BibTeX
@article{Moradi2025,
  author = {Moradi, Kamyar and Mohajer, Bahram and Guermazi, Ali and Hadidchi, Roham and Mohammadi, Soheil and Cao, Xu and Wan, Mei and Roemer, Frank W and Demehri, Shadpour},
  title = {Statin use and longitudinal bone marrow lesion burden: analysis of knees without osteoarthritis from the Osteoarthritis Initiative study},
  journal = {Skeletal Radiology},
  year = {2025},
  volume = {54},
  number = {8},
  pages = {1707--1714},
  doi = {10.1007/s00256-025-04878-6}
}
Kostenlos starten →